Instem Reports a Strong H1 2022

Proactive interview with Phil Reason,
Instem CEO

Investor Meet Company: Results and Company Update
September 2022

Presentation now available to watch on-demand

Watch Now

A global provider of leading software solutions
and services to the life sciences community.

The future transformed for the benefit of everyone.
Intelligent solutions empowering collaboration and life-enhancing science.

Learn more

Creating a more connected ecosystem in the
life sciences industry by consolidating and
harmonizing a fragmented IT marketplace.

Learn more

Welcome to the Instem Investor Centre

Instem (AIM:INS.L) is a leading provider of IT solutions and services to the global early development healthcare market, delivering compelling solutions for data collection, analysis and regulatory submissions management.


Latest News

09 January 2023 - Appointment of Independent Non-Executive Director

Read More

22 December 2022 - Contract Extension with Leading CRO

Read More

12 October 2022 - Exercise of Options, Issue of Equity and Total Voting Rights

Read More

Annual Report 2021

Impressive growth in FY22

Annual Report 2021

Our achievements and performance in 2021 have been exceptional and we have accomplished a fundamental strategic shift in scale and reach having completed three important acquisitions.

Impressive growth in FY22

Research Note by Gareth Evans of Progressive Equity Research